Renal agents

Haemodialysis and peritoneal dialysis: an overview

A summary of the different types of renal replacement therapy and the physiological implications of end-stage renal disease on medicines dosing and monitoring.…

Optimising use of SGLT2 inhibitors in hospital patients

How pharmacists can evaluate SGLT2 inhibitor use in hospitalised patients with a well-balanced approach so that patients can simultaneously benefit from SGLT2 inhibitors and the reduction of diabetic ketoacidosis risk.…

NICE recommends vadadustat for anaemia during dialysis for chronic kidney disease

Draft guidance says that vadadustat is a cost-effective oral alternative to erythropoiesis stimulating agents for the treatment of anaemia in patients with chronic kidney disease receiving dialysis.…

Kidney stones: symptoms, diagnosis and management

Kidney stones are a source of significant patient morbidity. Pharmacists can have an impact in identifying, triaging and supporting patients with the management of this condition.…

Test your knowledge of sexual and reproductive health

This CPD and learning quiz can help you assess your knowledge of a range of sexually transmitted infections and related health issues.…

Rapid UTI test wins £8m Longitude Prize on Antimicrobial Resistance

The winning test uses a urine sample on a smartphone-sized cartridge to identify the presence of a bacterial infection in 15 minutes and the antibiotic required within 45 minutes.…

First-in-class antibiotic provides effective treatment for UTIs, trial results suggest

Gepotidacin showed non-inferiority to nitrofurantoin in one trial and superiority in another.…

Benign prostatic hyperplasia

Symptoms and management options for this common urological condition.…

NICE says more evidence needed for newer UTI point-of-care tests

Several newer point-of-care tests were not recommended in latest guidance from the National Institute for Health and Care Excellence, in which it concluded that more research needs to be carried out on their accuracy.…

NICE approves new drug for chronic kidney disease and diabetes 

Results from a phase III study of more than 5,000 adults suggested that finerenone improved kidney function and helped slow the worsening of chronic kidney disease.…